Article | September 17, 2021

AI(d) To Increase Drug Discovery Productivity And Optimize SPR Data Interpretation

Source: Cytiva

By Paul Belcher, Product Strategy Manager, and Martin Teichert, Global Product Manager, Cytiva

iStock-1206796363-ai-artificial-intelligence-machine-learning-technology

Due to the high attrition rates in drug development, there is increasing pressure in the pharmaceutical industry, yet the efficiency of research and development has not increased. Developers have more samples to test and more information to collect, with less time to make decisions.

Therefore, there’s demand for information-rich technologies that can be applied earlier in the drug discovery process. While some of the current data analysis tools have improved, developers are still faced with time-consuming, manual approaches.

Explore a machine learning solution to optimize how developers analyze and characterize their early drug candidates.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Drug Discovery Online? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: